NH-Amundi Bio Korea Active ETF (498050)

Market Open

12 Aug, 02:38

KRX SM

₩

11,605. 00

-370

-3.0898%

- Market Cap

- Div Yield

33,991 Volume

₩ 11,975

Previous Close

Add Transaction

Day Range

11,575 11,895

Year Range

9,105 18,200

Want to track 498050 and more in your Portfolio? 🎯

Get Started For Free

Summary

498050 trading today lower at ₩11,605, a decrease of -3.0898% from yesterday's close, completing a monthly decrease of -9.5127% or -₩1,220. Over the past 12 months, 498050 stock lost -27.8072%.

498050 is not paying dividends to its shareholders.

The stock of the company had never split.

The company's stock is traded on one exchange.

Overview
Historical Data

498050 Chart

NH-Amundi Bio Korea Active ETF (498050) FAQ

What is the stock price today?

The current price is ₩11,605.00.

On which exchange is it traded?

NH-Amundi Bio Korea Active ETF is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 498050.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has NH-Amundi Bio Korea Active ETF ever had a stock split?

No, there has never been a stock split.

NH-Amundi Bio Korea Active ETF Profile

KRX SM Exchange

South Korea Country

Overview

The NH-Amundi Bio Korea Active ETF embodies a strategic investment vehicle primed to harness the growth of South Korea's biotechnology sector. This actively managed exchange-traded fund is expertly designed to track the burgeoning biopharmaceutical and healthcare industries within the region, serving as a beacon for investors aiming to tap into the innovative advances and robust growth of these sectors. Its partnership with the Amundi asset management group, one of Europe's leading asset managers, furnishes it with superior research capabilities and insights, thereby bolstering its position as an indispensable tool for investors seeking specialized exposure to the promising life sciences industry in South Korea.

Products and Services

NH-Amundi Bio Korea Active ETF

Focus on Biotechnology Sector in South Korea: The ETF zeroes in on the biotechnology landscape of South Korea, ensuring investments are directed towards companies that are at the forefront of biopharmaceutical and healthcare innovations. By prioritizing entities that push the envelope in medical research and development, the fund positions itself as a pivotal player for investors wanting a piece of this dynamic sector.

Actively Managed: Unlike typical ETFs that follow a passive investment strategy tracking a predetermined index, the NH-Amundi Bio Korea Active ETF is managed by a dedicated team of professionals. This approach allows for dynamic portfolio adjustments in response to evolving market trends and sector-specific developments, potentially enhancing the fund's performance by capturing growth opportunities as they arise.

Diversified Investment Portfolio: The fund diversifies its investments across a broad array of companies within the healthcare, pharmaceuticals, and biotech industries. This strategic diversification minimizes risk by spreading exposure across various players, from established firms to rising innovators, that contribute to advancements in global health solutions and medical technologies.

Part of the Amundi Asset Management Group: Aligning with the Amundi asset management group extends several advantages to the NH-Amundi Bio Korea Active ETF, including access to vast research resources and deep market insights. Amundi’s reputation as one of Europe’s premier asset managers enhances the ETF’s credibility and supports its objective to deliver competitive investment results by leveraging expert market analyses and strategies.

Contact Information

Address: -

Phone: -

Blog Affiliate Program About Terms Privacy Help Contact Us